Saturday, 7 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capacity Expansion

Gland Pharma Capacity Expansion

Gland Pharma announced a long-term strategic CDMO partnership with Neuland Laboratories to expand its sterile API manufacturing infrastructure at its Visakhapatnam facility.

Source

NSE filing, NSE: GLAND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Gland Pharma Ltd: key numbers

Share price
₹3,169.30
Market cap
₹52,297 Cr
Revenue (annual)
₹6,431 Cr
Net profit (annual)
₹1,027 Cr
P/E (TTM)
42.3×Sector 43.0×
Promoter holding
45.75%-6.02% QoQ
FII holding
10.36%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gland Pharma Ltd

All →
11:28 IST NSE
Regulatory Approval

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

Other capacity expansion announcements

All →